Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Cancer Chemotherapy and Pharmacology|January 4, 2026
Prospective monitoring of plasma abemaciclib in breast cancer patients: associations with age and adverse eventsKeisuke Ikegami, Reiko Ando Makihara, Yuki Katsuya, et al.
Frontiers in Oncology|June 14, 2021
Absolute Lymphocyte Count Predicts Immune-Related Adverse Events in Patients With Non-Small-Cell Lung Cancer Treated With Nivolumab Monotherapy: A Multicenter Retrospective StudySaeka Egami, Hitoshi Kawazoe, Hironobu Hashimoto, et al.
Journal of Cancer|March 23, 2021
Peripheral blood biomarkers predict immune-related adverse events in non-small cell lung cancer patients treated with pembrolizumab: a multicenter retrospective studySaeka Egami, Hitoshi Kawazoe, Hironobu Hashimoto, et al.
Pediatrics International : Official Journal of the Japan Pediatric Society|January 8, 2019
Evaluation of aprepitant and fosaprepitant in pediatric patientsYoshimasa Saito, Tadashi Kumamoto, Takamichi Arima, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 27, 2026
Impact of weight loss on adverse events during chemoradiotherapy in patients with small cell lung cancer: a retrospective studyYoshimasa Saito, Mai Kawarade, Reiko Ando Makihara, et al.
International Journal of Clinical Oncology|December 20, 2019
Impact of peripheral neuropathy induced by platinum in first-line chemotherapy on second-line chemotherapy with paclitaxel for advanced gastric cancerRyo Otsuka, Satoru Iwasa, Takako Yanai, et al.
International Journal of Clinical Oncology|May 14, 2025
A randomized, double-blind, placebo-controlled phase III study evaluating the preventive effect of diclofenac cream on capecitabine-related hand-foot syndrome: study protocol of J-SUPPORT2401/JORTC-SUP06 (J-DIRECT)Yohei Iimura, Hiroshi Ishiguro, Hironobu Hashimoto, et al.
Anti-Cancer Drugs|June 25, 2016
Amrubicin in patients with platinum-refractory metastatic neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma of the gastrointestinal tractTomonori Araki, Atsuo Takashima, Tetsuya Hamaguchi, et al.
Frontiers in Oncology|October 21, 2022
Patient-associated risk factors for severe anemia in patients with advanced ovarian or breast cancer receiving olaparib monotherapy: A multicenter retrospective studyRyota Tashiro, Hitoshi Kawazoe, Kanako Mamishin, et al.
Scientific Reports|July 24, 2023
Clinical and biomarker factors affecting survival in patients with platinum-sensitive relapsed ovarian cancer receiving olaparib monotherapy: a multicenter retrospective studyRyota Tashiro, Hitoshi Kawazoe, Kanako Mamishin, et al.
Pageof 8